Navigation Links
Amgen Highlights Data To Be Presented At American Society of Clinical Oncology Annual Meeting
Date:5/15/2013

adverse reactions (> 20%) of Vectibix are skin rash with variable presentations, hypomagnesemia, paronychia, fatigue, abdominal pain, nausea, diarrhea, including diarrhea resulting in dehydration.

The most serious adverse reactions of Vectibix are pulmonary fibrosis, pulmonary embolism, severe dermatologic toxicity complicated by infectious sequelae and septic death, infusion reactions, abdominal pain, hypomagnesemia, nausea, vomiting, and constipation.

To see the full Vectibix Prescribing Information, visit www.vectibix.com.

About Amgen
Amgen discovers, develops, manufactures and delivers innovative human therapeutics. A biotechnology pioneer since 1980, Amgen was one of the first companies to realize the new science's promise by bringing safe, effective medicines from lab to manufacturing plant to patient. Amgen therapeutics have changed the practice of medicine, helping people around the world in the fight against serious illnesses. With a deep and broad pipeline of potential new medicines, Amgen remains committed to advancing science to dramatically improve people's lives. For more information, visit www.amgen.com and follow us on www.twitter.com/amgen.

Forward-Looking Statements
This news release contains forward-looking statements that are based on management's current expectations and beliefs and are subject to a number of risks, uncertainties and assumptions that could cause actual results to differ materially from those described.  All statements, other than statements of historical fact, are statements that could be deemed forward-looking statements, including estimates of revenues, operating margins, capital expenditures, cash, other financial metrics, expected legal, arbitration, political, regulatory or clinical results or practices, customer and prescriber patterns or practices, reimbur
'/>"/>

SOURCE Amgen
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Amgen, Hospira and Sandoz Named Among Top Pharmaceutical Companies with Greatest Biosimilar Drug Potential in United States
2. Amgen And Zhejiang Beta Pharma Announce Planned Joint Venture In China
3. Amgens First Quarter 2013 Revenues Increased 5 Percent To $4.2 Billion And Adjusted Earnings Per Share (EPS) Increased 22 Percent To $1.96
4. Amgen Announces Webcast of 2013 First Quarter Financial Results
5. Zacks Industry Outlook Highlights: Eli Lilly, Novo Nordisk, Biogen, Amgen and Osiris Therapeutics
6. Amgen To Present At The Cowen and Company 33rd Annual Health Care Conference
7. Amgen Statement On Government Budget Analysis For Oral-Only Treatments For Dialysis Patients
8. Selexis Announces Expansion of R&D License Agreement with Amgen
9. Amgen Outlines Long-Term Strategy
10. Amgen and Peregrine Under StockCall Scrutiny: Pharma Stocks Deal with Drug Developments and Patents
11. Amgen To Webcast 2013 Business Review Meeting On February 7
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2015)... 27, 2015  A mere one in seven new ... Hamilton . A new white paper from ... impeding and disrupting manufacturers, success. The white ... Value In Product Development Processes provides insight into: ... how it affects the product development process resulting in: ...
(Date:8/27/2015)... Aug. 27, 2015 NorthStar Anesthesia , one ... it has been selected by Mercy, based in ... four of their hospitals:  Mercy St. Vincent  Medical Center and ... , Mercy St. Charles  Hospital in Oregon ... Tiffin . "As we looked to ...
(Date:8/27/2015)... , August 27, 2015 According ... Market by Type (Integrated, Standalone), by Deployment Mode (Web ... Physicians, Emergency Healthcare Service Providers), by Component - Global ... Systems Market is estimated at $501.1 Million 2014, and ... a CAGR of 7.6% from 2014 to 2019. ...
Breaking Medicine Technology:New White Paper Reveals How Manufacturers Can Improve Product Development Processes 2Four Mercy Hospitals in Northwest Ohio Select NorthStar Anesthesia 2Radiology Information Systems Market Worth $722.7 Million by 2019 2Radiology Information Systems Market Worth $722.7 Million by 2019 3Radiology Information Systems Market Worth $722.7 Million by 2019 4
(Date:8/28/2015)... (PRWEB) , ... August 28, 2015 , ... ... abuse, or those who might personally be struggling with chemical dependency, may be ... from Best Drug Rehabilitation, a results-driven holistic treatment center for addiction located in ...
(Date:8/28/2015)... ... 28, 2015 , ... Drugs and alcohol abuse by employees ... new approach on solutions in his new book ":Unraveling The Psychological Mystery of ... together for meaningful group meetings. "This would educate the employees on not ...
(Date:8/28/2015)... ... August 28, 2015 , ... Dr. Gregory K. Toumayan, D.C., Q.M.E., is now ... shoulder pain, hip pain, neck pain, stiffness, muscle spasms, and numbness. ... of Illinois, and then went on to earn his title of Doctor of Chiropractic ...
(Date:8/28/2015)... ... August 28, 2015 , ... Mendon, IL, home of the Adams County Fairgrounds, ... all for a good cause. In its second year, the “Music With A Mission” ... Drug Rehabilitation. The “Mission” of “Music With A Mission” is to raise money to ...
(Date:8/28/2015)... ... 28, 2015 , ... The newest therapy to receive orphan drug status for ... time soon, according to educational website Surviving Mesothelioma. Click here to read their ... for mesothelioma last week from the FDA, will now head into Phase I clinical ...
Breaking Medicine News(10 mins):Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 2Health News:Best Drug Rehabilitation Releases New Video Outlining Patients' Personal Recovery Stories 3Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 2Health News:Healthpointe Welcomes Dr. Gregory K. Toumayan, Chiropractor, to Colton, Temecula, and Perris 3Health News:Best Drug Rehabilitation Sponsors "Music With A Mission" Concert Featuring Avenue Beat 2Health News:Surviving Mesothelioma Puts New Orphan Drug into Perspective in New Article 2
... a leading,international manufacturer, marketer, and supplier of protective ... 2007 fourth,quarter and full year financial results., ... generated net sales of,$253.7 million, an increase of ... fourth quarter of 2006. Excluding the impact of ...
... therapy has an impact on overall day-to-day living, experts ... issues should be weighed carefully when prostate cancer patients ... them, new research suggests. , Different therapies can ... living, and these outcomes need to be discussed with ...
... WASHINGTON, March 19 Health and Human,Services Secretary ... by Deirdre McQuade, spokesperson on pro-life issues for,the ... comments on March 19,following a public attack on ... The attack was prompted by a March ...
... and other chemicals in childhood may hike adult cancer risks, ... In the decades following World War II, both breast cancer ... United States -- and a new report contends there,s a ... Breast Cancer Fund, a non-profit group whose mission is to ...
... International Associates Inc.,administrator for the HealthShares(TM) Indexes, a series ... announced the,quarterly rebalancing of the Indexes., The following ... before the opening of trading on NYSE Arca March ... GW Pharmaceuticals, Inc (LSE: GWP.L) ...
... March 19 Integrated,Pharmaceutical, Inc. (OTC Bulletin ... orders for its new no calorie, electrolyte ... and Magnesium, called,HEALTHYCAL+. The first bottles are ... Sales representatives report more than 40 ...
Cached Medicine News:Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 2Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 3Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 4Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 5Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 6Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 7Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 8Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 9Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 10Health News:Pregis Announces Fouth Quarter and Full Year 2007 Financial Results 11Health News:Quality of Life an Issue in Prostate Cancer Treatment 2Health News:Quality of Life an Issue in Prostate Cancer Treatment 3Health News:HHS Secretary Leavitt Praised for Defending Physicians' Conscience Rights 2Health News:Environmental Toxins, Radiation May Be Tied to Breast Cancer 2Health News:Environmental Toxins, Radiation May Be Tied to Breast Cancer 3Health News:Environmental Toxins, Radiation May Be Tied to Breast Cancer 4Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 2Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 3Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 4Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 5Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 6Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 7Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 8Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 9Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 10Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 11Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 12Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 13Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 14Health News:QED International Associates Announces Quarterly Rebalancing of HealthShares(TM) Indexes 15Health News:Retailers Sign on to Sell the New HEALTHYCAL+ Water Beverage - Even Before First Bottle is Packaged 2Health News:Retailers Sign on to Sell the New HEALTHYCAL+ Water Beverage - Even Before First Bottle is Packaged 3
A budget-priced microscope designed for ENT and neuro surgery....
The OPMI Neuro/NC4 System is the system of choice for integration with every major Image Guided Surgery (IGS). It can be mounted on NC4 floorstand or ceiling mount....
... microscope system has been designed ... fatigue. The maneuverability of this ... provides fatigue-free viewing even at ... as in posterior fossa, cerebral ...
... The XL Advantage delivers higher magnification ... a crisp, true image, even at the ... to edge clarity and precise color rendition ... treated with an anti-reflective coating produce a ...
Medicine Products: